HCA Healthcare, Inc. (HCA) Stock Forecast & Price Target
HCA Healthcare, Inc. · NYSE
$415.74-6.09 (-1.44%)
15-min delayed · Sep 10, 10:30 AM ET · Get real-time quotes →
The Quantellect read.Of the 20 firms covering HCA Healthcare, Inc, 13 rate it Buy or better, 6 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $380.00 to $590.00, a moderate spread. The average target of $471.60 sits 13% above the current $415.74. The rating mix has stayed broadly stable, with Buy-side ratings easing from 14 to 13 over recent months. On the fundamentals, the Street sees consensus EPS building from about $8.01 next quarter toward $32.07 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS20 ratings
Moderate Buy
Strong Buy00%
Buy1365%
Hold630%
Sell15%
Strong Sell00%
Based on 20 analysts giving stock ratings to HCA Healthcare, Inc.
As of Sep, 13 of 20 firms rate HCA a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
HCA EPS & revenue forecast
EPS · NEXT QUARTER
$8.01
Range $7.57 – $8.61 · 19 analysts · +0% YoY
Next period, 19 analysts expect HCA Healthcare, Inc. to earn $8.01 a share (range $7.57 – $8.61), versus $8.01 a year earlier. Full-year consensus is $29.49, growing to $32.07 the year after.
REVENUE · NEXT QUARTER
$19.9B
Range $19.2B – $20.3B · 19 analysts · +2% YoY
Revenue is expected to reach $19.9B (range $19.2B – $20.3B), +1.7% year-over-year. Full-year consensus is $78.5B, rising to $81.6B next year.
Top analysts covering HCA Healthcare, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HCA.
#1
DM
David Macdonald
Truist Securities · Rank #109
Buy
$495.00+19.1% to target
Overall win rate
48%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #149
Buy
$435.00+4.6% to target
Overall win rate
44%
+ Follow
#3
Brian Tanquilut
Jefferies · Rank #208
Buy
$450.00+8.2% to target
Overall win rate
42%
+ Follow
#4
Andrew Cooper
Raymond James · Rank #410
Hold
No targeton HCA
Overall win rate
24%
+ Follow
#5
Stephen Baxter
Wells Fargo
Hold
$381.00-8.4% to target
Coverage
—
+ Follow
HCA stock forecast FAQ
What is HCA's average 12-month price target?+
The 20 analysts with a live target average $471.60 for HCA Healthcare, Inc. over the next 12 months, ranging from a $590.00 high to a $380.00 low.
Is HCA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 20 analyst ratings, 13 are Buy or Strong Buy, 6 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for HCA?+
The Street-high target is $590.00 (Jefferies), and the Street-low is $380.00 (Morgan Stanley). The average of all 20 active targets is $471.60.
How many Wall Street analysts cover HCA?+
20 analysts have an active rating on HCA Healthcare, Inc., and 20 firms carry a live 12-month price target.
Who is the most accurate analyst covering HCA?+
Among analysts who currently cover HCA, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #109). Their current call is Buy with a $495.00 target.
What is HCA Healthcare, Inc.'s projected EPS for next quarter?+
The consensus estimate is $8.01 per share (range $7.57 – $8.61) across 19 analysts. Full-year EPS is projected at $29.49, rising to $32.07 the following year.
How much revenue is HCA Healthcare, Inc. expected to report next quarter?+
Consensus revenue is $19.9B (range $19.2B – $20.3B). Full-year revenue is projected at $78.5B, growing to $81.6B next year.
Have analysts been upgrading or downgrading HCA lately?+
As of Sep, 13 of 20 firms rate HCA a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HCA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
